Actively Recruiting
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Led by 4th Military Clinical Hospital with Polyclinic, Poland · Updated on 2024-11-27
32
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to improve the safety of the electroporation ablation (PFA) procedure by using muscle relaxants to reduce skeletal muscle damage during the procedure. It will also assess myocardial damage to improve the procedure's quality and speed up recovery after the procedure.
CONDITIONS
Official Title
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who require PFA ablation for heart conditions
- Ability to provide informed consent for study participation
You will not qualify if you...
- Allergies to the general anesthetics used
- Genetic neuromuscular diseases such as Duchenne dystrophy or myasthenia gravis
- Patients who do not give informed consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
4th Military Clinical Hospital with Polyclinic
Wroclaw, Lower Silesian Voivodeship, Poland, 50-981
Actively Recruiting
Research Team
M
Marek Szamborski, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here